<p> Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas, Inc. (NAPPSA)</p><p>2011 Annual Scientific Conference and Exposition</p><p>September 15 - 18, 2011</p><p>Conference Theme </p><p>Innovation and Change: Gateway to a New Pharmaceutical Frontier</p><p>Attendees May Earn up to 20 ACPE Continuing Education Credits Depending on Sessions Attended</p><p>Sheraton Gateway Los Angeles Hotel 6101 West Century Blvd, Los Angeles, CA 90045 Phone: 310-642-4048</p><p>Visit www.nappsa.org for more information</p><p>© 2011 NAPPSA, Inc. All Rights Reserved THURSDAY SEPTEMBER 15, 2011</p><p>12:00 Noon – 5:00 pm Registration</p><p>GENERAL SESSION</p><p>3:30 pm – 7:30 pm Session # 990: US-Nigeria Collaborations and Innovation Initiatives (3 hours CE) (Venue TBD)</p><p>3:30 pm #991: Improving Patient Outcome through Clinical Data Integration - Ayoola Kalejaiye, R.Ph., MBA, President, MedisoftRx, Corona, CA, USA</p><p>3: 55 pm #992: Introducing Innovative Prescription Drug Labeling and Dispensing Technology into Pharmacy Practice in Nigeria - Vernatius Ohaya, R.Ph., MBA, Director, Trustee Drugs, Atlanta, GA, USA</p><p>4:20 pm #993: Pharmacy and National Development in Nigeria: The Missing Link – Azubuike Okwor, FPSN, FPCPharm, President, Pharmaceutical Society of Nigeria, Lagos, Nigeria</p><p>4:45 pm #994: Europe-Africa Collaborative Initiative on Tropical Diseases - Augustine O Okhamafe, Ph.D, Professor of Pharmaceutics & Pharmaceutical Technology, Faculty of Pharmacy, University of Benin, Benin City, Nigeria. </p><p>5:10 pm #995: RISE Global Health Initiative: Opportunities for International Collaboration in the Academic and Clinical Setting - Palmer Taylor, Ph.D., Sandra and Monroe Trout Professor of Pharmacology, and Dean, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA., USA. </p><p>5:35 pm #996: Innovative Trends in Pharmacy Practice in Nigeria: A Regulatory Perspective – Ahmed Mora, FPSN, Registrar, Pharmacists Council of Nigeria (PCN), Abuja, Nigeria.</p><p>6:00 pm #997: Nigeria’s “Vision 20:2020” – Urgently Needed Reform for Success in the Healthcare Sector - Echeazu Ogu, Ph.D., RAC, Independent Pharma & Biomed Consultant/Trainer, Newark, DE, USA </p><p>6:25 pm – 7:30 pm Panel Discussion and Audience Interaction</p><p>Session Panelists: All Speakers Azikiwe Onwualu, PhD., Director General and Chief Executive Officer Raw Materials Research and Development Council (RMRDC), Abuja, Nigeria. Charles O Esimone, Ph.D., Professor of Biopharmaceutics & Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria. Festus Ogunbona, Ph.D., National Universities Commission, Abuja, Nigeria. Cyril Usifoh; Ph.D., Professor of Pharmacy, Faculty of Pharmacy, University of Benin, Benin, Nigeria Ifeanyi Atueyi, FPSN, Publisher, Pharma News, Lagos, Nigeria Chukwuemeka Okeke, MS, University of California San Diego School of Pharmacy, USA Ejiro Foyibo, Pharm.D., Chair, Community Pharmacists Association of Nigeria Pharm (Mrs.) M. Okpeseyi, Head of Department, Food and Drug Services, Federal Ministry of Health, Abuja, Nigeria</p><p>© 2011 NAPPSA, Inc. All Rights Reserved Dr. (Mrs.) O.R. Olowu, mni., Desk Officer in Charge of Diaspora, Federal Ministry of Health, Abuja, Nigeria</p><p>Session Moderator – Eucharia E. Nnadi, R.Ph., J.D., Ph.D., Vice President for Academic Affairs & Program Planning, University of Southern Nevada, Henderson, NV, USA</p><p>7:15 pm Moderators’ Meeting</p><p>7:30 pm Welcome Reception & Networking - TBD FRIDAY SEPTEMBER 16, 2011</p><p>7:00 am – 7:45 am Breakfast</p><p>7:00 am – 5:00 pm Registration</p><p>7:45 am Opening Ceremony (Venue: TBD)</p><p>Welcome Remarks: Nnodum Iheme, R.Ph., President, Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) Inc., Cincinnati, OH, USA</p><p>8:00 am – 9:00 am Session # 100: Keynote Presentation (1 hour CE) (Venue: TBD)</p><p>Leveraging Innovation and Change through Regulatory Science Initiatives – ShaAvhree Buckman, M.D., Ph.D., FAAP, Director, Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD.</p><p>8:50 am – 9:00 am Q&A and Audience Interaction</p><p>9:00 am – 9:15 am Break</p><p>GENERAL SESSION</p><p>9:15 am – 12:15 pm Session # 200: Healthcare Innovation in Africa: Past, Present and Future (3 hours CE)</p><p>9:15 am #201: Science, Technology and Innovation in the Nigerian Healthcare Industry - Azikiwe Onwualu, PhD., Director General and Chief Executive Officer Raw Materials Research and Development Council (RMRDC), Abuja, Nigeria.</p><p>9:45 am #202: Public Policy Incentives to Promote Medical Product Innovation: What Can Nigeria learn from the Developed Economies? - Ekopimo Ibia, M.D., M.P.H., Director and US Regulatory Policy Lead, Merck & Co., Inc., Bethesda, MD, USA</p><p>10:15 am #203: NAPPSA Roadmap: Implementation Update – Ngozi Erondu, M.D., Ph.D., Senior Director, Clinical Development, TB Alliance, New York, NY., USA or Yetunde Taiwo, Ph.D., Director, Global External Research & Development, Lilly Research Laboratories, Indianapolis, IN., USA.</p><p>© 2011 NAPPSA, Inc. All Rights Reserved 10:45 am #204: Innovation in Big Pharma: What does the data say and what does innovation really mean for a service company? - Derek G. Hennecke, MBA, President & CEO Xcelience LLC, Tampa, Florida, USA</p><p>11:15 am #205: Strengthening Institutional Review Boards / Independent Ethics Committee: Case Study Kenya - Catherine Wangui Wachira, M.S., MBA, Senior Director, Business Operations and Compliance, Clinical Development and Medical Affairs, Pfizer Inc., New York, NY., USA.</p><p>11:45 am – 12:15 pm Panel Discussion and Audience Interaction</p><p>Session Panelists: All speakers Uford Inyang, Ph.D., Former Director-General and CEO, National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, Nigeria. Linus N. Igwemezie, Ph.D., MBA, Vice President and Global Head, New Products Strategy, Novartis Pharmaceutical Corporation, Florham Park, NJ, USA. Yetunde Taiwo, Ph.D., Director, Global External Research & Development, Lilly Research Laboratories, Indianapolis, IN., USA. Vincent Ahonkhai, M.D., Senior Regulatory Officer, Global Health Delivery, Bill and Melinda Gates Foundation, Seattle, WA., USA. Sam Yoren, M.D., Vice President, Global Medical Safety, Alcon Laboratories, Inc. Okpo Eradiri, Ph.D., Vice-President Biopharmaceutics & Toxicology, Biovail Technologies, Ltd. Chantilly, VA, USA ShaAvhree Buckman, M.D., Ph.D., FAAP Director, Office of Translational Sciences (OTS), CDER, US Food and Drug Administration, Silver Spring, MD. Simon Agwale, Ph.D., CEO, Innovative Biotech Inc., Frederick, MD., USA.</p><p>Session Moderator – Henrietta Ukwu, M.D., FACP, FRAPS, Senior Vice President, Global Regulatory Affairs, Pharmaceutical Product Development (PPD) Inc., Blue Bell, PA., USA.</p><p>12:15 pm Lunch Break</p><p>12:15 pm – 3:00 pm Exhibition and Poster Session </p><p>GENERAL SESSION </p><p>3:00 pm – 5:00 pm Session #300: Regulatory Science (2 hours CE)</p><p>3:00 pm #301: Regulation of Nonprescription Products - The Basics and New Directions - M. Scott Furness, Ph.D., Director, Division of Nonprescription Regulation Development, Office of New Drugs, Center for Drug Evaluation and Research, U.S. FDA, Silver Spring, MD., USA</p><p>3:50 pm #302: Update on US Regulatory Approaches in Generic Drug Approval - Barbara Davit, Ph.D., J.D., Acting Director, Division of Bioequivalence II, Center for Drug Evaluation and Research, U.S. FDA, Rockville, MD., USA</p><p>4:40 pm – 5:00 pm Q&A and Audience Interaction </p><p>© 2011 NAPPSA, Inc. All Rights Reserved Session Moderator – Okpo Eradiri, Ph.D., Principal Consultant, Parexel International, Bethesda, MD, USA. </p><p>5:00 pm – 9pm Bus Tour de Los Angeles</p><p>9.00 pm – 2am Young Professionals Reception</p><p>9.30pm – 10.30pm Career Opportunities Round Table Discussion</p><p>10:00pm Q & A</p><p>SATURDAY SEPTEMBER 17, 2011</p><p>6:30 am – 7:45 am Breakfast</p><p>7:00 am – 5:00 pm Registration</p><p>PARALLEL SESSION (Pharmaceutical Care/Practice)</p><p>7:00 am – 10:00 am Session #550: Pharmacy Business (2 hours CE)</p><p>7:00 am #551: DMEPOS Update for Pharmacies: 2011 and Beyond – Geoff Krueger, RRT, RCP, President, Proactive Solutions HME Consulting LLC, Toledo, OH, USA</p><p>7:20 am #552: Business to Business Relationship: An Update – Emmanuel Ezirim, R.Ph., President, Central Point Pharmacy, Columbus, OH., USA</p><p>Banji Adereti, R.Ph., President, Elim Pharmacy, Los Angeles, CA, USA. </p><p>7:40 am #553: The 340B Drug Pricing Program: Opportunities for Pharmacies – Daniel Neal, Senior Product Development Manager, Cardinal Health, Columbus, OH, USA</p><p>8:25 am #554: Marketing Your Own Pharmacy – Carla Cantrell, Manager, Local Store Marketing, Cardinal Health, Dublin, OH, USA. </p><p>9:15 am– 10:00 am Q&A and Audience Interaction</p><p>Session Panelists: All speakers Other Panelists - TBD.</p><p>Session Moderator – Femi Omodara R.Ph., Pharmacist, Park Central Pharmacy, Phoenix, AZ, USA</p><p>PARALLEL SESSION (Pharmaceutical Science)</p><p>8:00 am – 10:00 am Session #500: Quality in Drug Development and Manufacturing (2 hours CE)</p><p>© 2011 NAPPSA, Inc. All Rights Reserved 8:00 am #501: Biopharmaceutics and Quality by Design: U.S. Regulatory Perspective – Arzu Selen, Ph.D., Biopharmaceutics Research Lead, Office of New Drug Quality Assessment, CDER, US FDA</p><p>8:50 am #502: Good Manufacturing Practice: Is It Possible in Developing Countries? - Patrick Lukulay, Ph.D., Director, Drug Quality and Information, United States Pharmacopeia, Rockville, MD., USA.</p><p>9:40 am – 10:00 am Q&A and Audience Interaction </p><p>Session Moderator – Funmi Ajayi, Ph.D., Senior Director, Department of Experimental Medicine and Drug Safety, New Technology Development, Proctor & Gamble Pharmaceuticals, Cincinnati, OH, USA</p><p>PARALLEL SESSION (Pharmaceutical Care/Practice)</p><p>10:15 am – 12:15 pm Session #450: Medication Safety (2 hours CE) </p><p>10:15 am #451: Medication Errors and Their Legal Consequences – Ned Milenkovich, Pharm.D., J.D., Chair, Drug & Pharmacy Practice, McDonald Hopkins LLC, Chicago, Illinois, USA.</p><p>11:05 am #452: The Pharmacist’s Role in Detecting and Preventing Controlled Drug Substance Diversion –Michael Lewis, Diversion Program Manager, Los Angeles Field Division, Drug Enforcement Agency (DEA), Los Angeles, CA, USA.</p><p>11:55 am – 12:15 pm Q&A and Audience Interaction</p><p>Session Moderator – Steve Adekoya, R.Ph., Owner and CEO, Preskey Pharmacy, Baltimore, MD, USA</p><p>PARALLEL SESSION (Pharmaceutical Science)</p><p>10:15 am – 12:15 pm Session #400: Drug Discovery and Delivery Systems (2 hours CE) </p><p>10:15 am #401: Orally Dissolving Film (ODF) Strips as a Vector for Small and Large Molecules Micro/Nanoparticles Delivery - Carmen Popescu, Ph.D., Project Coordinator, Pharmaceutical Applications, Roquette America, Inc., Geneva, IL, USA.</p><p>11:05 am #402: Recombinant Viral Vectors as Probes for High Through-put Screening of Potential Antiviral Agents - Charles O. Esimone, Ph.D., Professor of Biopharmaceutics & Pharmaceutical Microbiology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria.</p><p>11:55 am – 12:15 pm Q&A and Audience Interaction</p><p>Session Moderator – Simon Agwale, Ph.D., CEO, Innovative Biotech Inc., Frederick, MD., USA.</p><p>12:15 pm Lunch Break</p><p>12:15 pm – 3:00 pm Exhibition and Poster Session</p><p>© 2011 NAPPSA, Inc. All Rights Reserved GENERAL SESSION</p><p>3:00 pm – 5:00 pm Session #600: Women and Health (2 hours CE)</p><p>3:00 pm #601: Complications of Pregnancy: Diagnosis and Management – Iheanacho Emeruwa, M.D., Medical Director, Aspen Medical Group, Inc., Riverside, CA, USA</p><p>3:30 pm #602: Common Gynecologic Disorders: Innovative Treatment Strategies in Nigeria - Nicholas Ohaya, M.B.B.S., FWACS, Consultant and Head, Department of Obstetrics and Gynaecology, Nigerian Army Reference Hospital, Lagos and, Medical Director, Trustee Specialist Hospital Nig. Ltd, Lagos, Nigeria</p><p>4:00 pm #603: Breast and Gynecologic Cancers: Diagnosis and Treatment – Olukemi Wallace, M.D., Medical Director & Consultant, Healinghands Oncology and Medical Care, Inc., Lawndale, CA, USA</p><p>4:30 pm – 5:00 pm Q&A and Audience Interaction </p><p>Session Moderator – Abimbola Adebowale, Ph.D., Clinical Pharmacology Reviewer, Division of Clinical Pharmacology 3, Office of Clinical Pharmacology, U.S. FDA, Silver Spring, MD, USA</p><p>5:00 pm – 6:30 pm NAPPSA General Meeting and Elections</p><p>8:00 pm Conference Banquet</p><p>SUNDAY SEPTEMBER 18, 2011</p><p>7:00 am – 8:00 am Breakfast</p><p>GENERAL SESSION</p><p>7:00 am – 8:00 am Session #350: Pharmacogenetics and Pharmacogenomics (2 hours CE)</p><p>7:00 am #350: Pharmacogenomics: Tailoring Drug Therapy to our Genes – Okezie I. Aruoma, MBA, Ph.D., D.Sc., Professor, Department of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, USA</p><p>Session Moderator – Soji Akanwo, R.Ph., Co-Owner, Paradise Hills Pharmacy, San Diego, CA, USA</p><p>GENERAL SESSION</p><p>8:00 am – 10:00 am: Session #700: Disease State Management (2 hour CE)</p><p>8:00 am #701: HIV/AIDS Update: A Case-Based Approach – Tina Edmunds-Ogbuokiri, Pharm.D., Associate Professor, Xavier University College of Pharmacy, New Orleans, Louisiana, USA.</p><p>© 2011 NAPPSA, Inc. All Rights Reserved 8:50 am #702: Heart Disease and Sudden Death – Leo Egbujiobi, R.Ph., M.D., Chief of Cardiology & Cardiac Surgery, Beloit Memorial Hospital, Beloit, WI, Clinical Professor of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.</p><p>9:40 am – 10:00 am General Q & A and Audience Interaction</p><p>Session Moderator – Chinyere Onyebuchi, Project Manager, Infectious Disease, Merck & Co., Inc., Kenilworth, NJ, USA</p><p>10:00 am Closing Ceremony</p><p>2011 NAPPSA Conference Program Committee</p><p>Anthony C. Ikeme (Chair), Imo Ibia, Nnodum Iheme, Patrick Nwakama, Echeazu Ogu, Abimbola Adebowale (Co-Secretary), Chinyere Onyebuchi (Co-Secretary), Femi Omodara, Ayo Kalejaiye, Ify Udeze, Theo Gana, Yemi Ako</p><p>© 2011 NAPPSA, Inc. All Rights Reserved</p>